Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Protein-based Nanoparticles as an HIV Vaccine Platform

EF 2015-16

Résumé
Over the past 25 years, efforts have failed to develop a vaccine capable of broadly protecting against HIV. In response to HIV, the immune system seems generally unable to respond effectively, providing limited protection to the infected individual. Past HIV vaccine candidates have been met with similar challenges, where they are unable to elicit a broadly protective response. Thus, improvements must be made to increase specificity and breadth of the immune response to an HIV vaccine. Towards this goal, multimeric components (antigens) have been demonstrated to be more effective in activating the immune system in comparison to monomeric antigens, due to their ability to activate several receptors on immune cells (B cells) simultaneously. In order to improve current HIV antigens and create an improved immune response, I propose to design a novel platform based on self-assembling protein-based nanoparticles to present multimers of HIV antigens to the immune system. I will then test these nanoparticles in B cells to determine their activation potential. It is predicted that the development of protein nanoparticles as a multimerization platform for HIV antigens will enable broad reactivity and enhance immune memory to vastly improve the efficiency of current HIV vaccination strategies.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
350071
Name
Sicard Taylor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Protein-based Nanoparticles as an HIV Vaccine Platform
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
B Cells; Biochemistry; Hiv; Immunology; Nanotechnology; Protein Engineering; Vaccines
Abstract
Over the past 25 years, efforts have failed to develop a vaccine capable of broadly protecting against HIV. In response to HIV, the immune system seems generally unable to respond effectively, providing limited protection to the infected individual. Past HIV vaccine candidates have been met with similar challenges, where they are unable to elicit a broadly protective response. Thus, improvements must be made to increase specificity and breadth of the immune response to an HIV vaccine. Towards this goal, multimeric components (antigens) have been demonstrated to be more effective in activating the immune system in comparison to monomeric antigens, due to their ability to activate several receptors on immune cells (B cells) simultaneously. In order to improve current HIV antigens and create an improved immune response, I propose to design a novel platform based on self-assembling protein-based nanoparticles to present multimers of HIV antigens to the immune system. I will then test these nanoparticles in B cells to determine their activation potential. It is predicted that the development of protein nanoparticles as a multimerization platform for HIV antigens will enable broad reactivity and enhance immune memory to vastly improve the efficiency of current HIV vaccination strategies.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sicard, Taylor
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~